Wednesday, April 3, 2024
Understand ICH Q7 S2
Should GMP according to ICH Q7 be applied for manufacturing steps before the defined ‘API starting material' i.e. steps not identified in grey in Table 1?
ICH Q7 does not apply to steps prior to the introduction of
the API starting material. However, there is an expectation
that an appropriate level of controls suitable for the
production of the API starting material should be applied
[ICH Q7, 1.3].
Normally, the ‘API-starting material’ is defined in the
regulatory filing by the applicant and approved in the
regulatory reviewing process. Additional guidance is
provided to define and justify ‘API starting material’ derived
from various sources [ICH Q11, 5]; for master cell banks,
see [ICH Q5B; ICH Q5D]
Subscribe to:
Post Comments (Atom)
Gap Assessment Schedule M
To conduct a **gap assessment** between the **old Schedule M** and the **revised Schedule M** of the **Drugs and Cosmetics Rules, 1945**, we...
-
An FDA Warning Letter is a formal communication from the US Food and Drug Administration (FDA) notifying a company or individual of regulato...
-
The significant violations of CGMP regulations for finished products, which are mentioned in the Warning Letter, are listed as follows: ...
-
The company experienced seven out-of-limit (OOL) events for microbial content in a system used to generate a major component of drug product...
No comments:
Post a Comment